Initiate Partnership Dialogue
View Technology Specifications
Translational Partnerships

Institutional co-development for targeted nanorobotics

Partner with Magnobot Med to integrate proprietary chemotherapeutic assets into our 120 nm magnetoelectric nanorobot delivery architecture.

Engagement Frameworks

Structured pathways for clinical and research integration

We offer modular commercial models tailored to pharmaceutical developers, academic institutions, and clinical trial sites.

Biopharma Payload Integration

Academic Research Consumables

Clinical Trial Hardware Leasing

Formulate proprietary chemotherapeutic compounds into our 120 nm magnetoelectric carriers for targeted solid tumour delivery.

Supply turnkey precision robotic consumables and microfluidic testing kits for translational oncology research.

Deploy custom 3D electromagnetic coil arrays and real-time software control systems for institutional in vivo validation.

Preclinical Validation

Advancing collaborative trials with academic medical centres

Following extensive in vitro and cell-culture validation demonstrating precise nanoscale actuation, Magnobot Med is establishing translational in vivo protocols with academic clinical partners such as AIIMS Delhi.

Our regulatory and clinical affairs division provides comprehensive biophysical documentation, safety profiling, and protocol design support to ensure rigorous compliance across all co-development milestones.

Initiate Partnership Dialogue

Schedule a confidential technical briefing

Connect with our clinical translation division to review non-disclosure data packages and co-development feasibility.